Medetomidine Hydrochloride
Medetomidine Hydrochloride is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.
Drug Details
- Generic Name
- Medetomidine Hydrochloride
- Brand Names
- N/A
- Application Number
- Sponsor
- Interquim, S.A. de C.V.
- NDC Codes
- 1
- Dosage Forms
- POWDER
- Routes
- N/A
- Active Ingredients
- MEDETOMIDINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS & USAGE Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is a relatively selective alpha 2 -adrenergic agonist indicated for: • Sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. Administer dexmedetomidine hydrochloride in 0.9% sodium chloride injection by continuous infusion not to exceed 24 hours. (1.1) • Sedation of non-intubated patients prior to and/or during surgical and other procedures. (1.2) 1.1 Intensive Care Unit Sedation Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. Dexmedetomidine hydrochloride in 0.9% sodium chloride injection should be administered by continuous infusion not to exceed 24 hours. Dexmedetomidine hydrochloride in 0.9% sodium chloride injection has been continuously infused in mechanically ventilated patients prior to extubation, during extubation, and post-extubation. It is not necessary to discontinue Dexmedetomidine hydrochloride in 0.9% sodium chloride injection prior to extubation. 1.2 Procedural Sedation Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures.